The evil relationship between liver fibrosis and cardiovascular disease in metabolic dysfunction-associated fatty liver disease (MAFLD): Looking for the culprit-Reference-Cited by-同舟云学术

The evil relationship between liver fibrosis and cardiovascular disease in metabolic dysfunction-associated fatty liver disease (MAFLD): Looking for the culprit

Published:2023-11 Issue: Volume: Page:166763
ISSN:0925-4439
Container-title:Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
language:en
Short-container-title:Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease

Author:

Fabris L.,Campello E.,Cadamuro M.,Simioni P.

Funder

European Commission

Ministero della Salute

University of Padua

Publisher

Elsevier BV

Subject

Molecular Biology,Molecular Medicine

Reference24 articles.

1. NAFLD vs. MAFLD - it is not the name but the disease that decides the outcome in fatty liver;De;J. Hepatol.,2022

2. The complex link between NAFLD and type 2 diabetes mellitus - mechanisms and treatments;Targher;Nat. Rev. Gastroenterol. Hepatol.,2021

3. Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis;Targher;J. Hepatol.,2016

4. Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up;Ekstedt;Hepatology.,2015

5. Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with non-alcoholic fatty liver disease;Angulo;Gastroenterology,2015

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Editorial for “MRI Extracellular Volume Fraction in Liver Fibrosis—A Comparison of Different Time Points and Blood Pool Measurements”;Journal of Magnetic Resonance Imaging;2024-03-29

2. Ductular Reactions in Liver Injury, Regeneration, and Disease Progression—An Overview;Cells;2024-03-26